Compare TRN & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRN | HTFL |
|---|---|---|
| Founded | 1933 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Railroads | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 1994 | N/A |
| Metric | TRN | HTFL |
|---|---|---|
| Price | $33.88 | $30.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $34.00 | ★ $38.20 |
| AVG Volume (30 Days) | 703.7K | ★ 1.1M |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ 85.98 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $2,156,900,000.00 | N/A |
| Revenue This Year | $1.91 | $27.66 |
| Revenue Next Year | $15.61 | $23.55 |
| P/E Ratio | $113.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.38 | $20.13 |
| 52 Week High | $37.36 | $41.22 |
| Indicator | TRN | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 54.05 | 54.41 |
| Support Level | $31.12 | $28.37 |
| Resistance Level | $35.33 | $32.69 |
| Average True Range (ATR) | 1.02 | 1.87 |
| MACD | 0.10 | -0.06 |
| Stochastic Oscillator | 76.69 | 60.81 |
Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.